Shopping Cart
Remove All
Your shopping cart is currently empty
Dalotuzumab (Synonyms: MK-0646, h7C10)
Catalog No. T76800 Copy Product Info
🥰Excellent
Dalotuzumab (MK-0646) is a recombinant humanized IgG1 monoclonal antibody that specifically targets the insulin-like growth factor 1 receptor (IGF-1R). its mechanism of action involves the inhibition of IGF-mediated oncogenic signaling, which subsequently induces apoptosis and cell cycle arrest in tumor cells, and it has demonstrated enhanced antitumor efficacy when used in combination with other chemotherapeutic agents.
Dalotuzumab
Copy Product Info🥰Excellent
Catalog No. T76800
Synonyms MK-0646, h7C10
Dalotuzumab (MK-0646) is a recombinant humanized IgG1 monoclonal antibody that specifically targets the insulin-like growth factor 1 receptor (IGF-1R). its mechanism of action involves the inhibition of IGF-mediated oncogenic signaling, which subsequently induces apoptosis and cell cycle arrest in tumor cells, and it has demonstrated enhanced antitumor efficacy when used in combination with other chemotherapeutic agents.
Dalotuzumab
Cas No. 1005389-60-5
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $645 | - | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,460 | - | In Stock | |
| 50 mg | $1,970 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:97.6% (SDS-PAGE); 99.3% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Dalotuzumab (MK-0646) is a recombinant humanized IgG1 monoclonal antibody that specifically targets the insulin-like growth factor 1 receptor (IGF-1R). its mechanism of action involves the inhibition of IGF-mediated oncogenic signaling, which subsequently induces apoptosis and cell cycle arrest in tumor cells, and it has demonstrated enhanced antitumor efficacy when used in combination with other chemotherapeutic agents. |
| In vitro | Dalotuzumab (33 nM, 24 h) was used to treat IGF-1-induced MCF7 cells, and the changes in cell cycle and the expression of IGF-IR and IRS-1 proteins were detected. Results: Dalotuzumab was able to induce cell cycle arrest in IGF-1-induced MCF7 cells and also inhibited the autophosphorylation of IGF-IR and IRS-1. [1] |
| In vivo | Methods: Dalotuzumab (MK-0646) (250 µg/mouse initially, then 125 µg/mouse, intraperitoneally twice a week for 40 days) was used to treat Swiss nude mice bearing MCF-7 and A549 xenograft tumors, and its tumor inhibition was observed. Results: Dalotuzumab reduced the average tumor volume of nude mice in the MCF-7 and A549 models by 70% and 72%, respectively. [1] |
| Synonyms | MK-0646, h7C10 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IGF1-R/IGFR1/CD221 |
| Molecular Weight | 146.36 kDa |
| Cas No. | 1005389-60-5 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Dalotuzumab | purchase Dalotuzumab | Dalotuzumab cost | order Dalotuzumab | Dalotuzumab in vivo | Dalotuzumab in vitro | Dalotuzumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.